A simple urine test devised by researchers at Stanford Medicine and the VA Palo Alto Health Care System can diagnose people ...
Kidney cancer accounts for 3 percent to 5 percent of all cancer cases. It is among the top 10 most common cancers. Kidney cancer may not cause any signs or symptoms in its early stages. It is often ...
Stanford Medicine researchers and collaborators developed an RNA-based urine test that could improve bladder cancer diagnosis ...
Urine cell-free (cf)RNA analysis could represent a promising biomarker for bladder cancer, according to a study published online Oct. 2 in Nature Medicine. Kevin J. Liu, PhD, from Stanford University ...
Researchers report that cigarette smoke drives bladder cancer aggressiveness through exosome-delivered circ55033, which ...
Urine analysis is a relatively simple, inexpensive, and noninvasive strategy for assessing biological parameters across ...
MUVON Therapeutics AG, a clinical-stage biotechnology company, reports positive 12-month interim results from the Long-Term Follow-Up Study of the Phase 2 clinical trial SUISSE-MPC2 (NCT05534269), ...
Researchers at Children's Hospital Colorado (Children's Colorado) and the University of Colorado Anschutz School of Medicine ...
A Stanford-led study finds Resero Bio’s uRARE-seq urine cfRNA test detects bladder cancer and predicts therapy response in 683 samples.
Resero Bio, a precision diagnostics company building a cell-free RNA (cfRNA) liquid biopsy platform, today announced ...
A simple urine test devised by researchers at Stanford Medicine and the VA Palo Alto Health Care System can diagnose people ...
Must-Read Posts In GU Oncology This Week / Action Kidney Cancer, bladder cancer, cancer, cancer care, Cancer research, cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results